Global Drug Discovery Technologies Market Projected to Reach $197 Billion by 2029
Revolutionizing Drug Research: AI and Genomics Drive Faster, More Successful Drug Discovery for Life-Saving Treatments BOSTON, Nov. 19, 2024 /PRNewswire/...
Pharmaceutical
SAS forecasts AI reality over hype for health care and life sciences in 2025
Pharma and health care industries take deliberate steps, not leaps, toward AI innovation and digital transformation CARY, N.C., Nov. 19,...
Roche Canada Announces New Informatics Jobs in Ontario’s Life Sciences Sector
These jobs will propel the province towards being a global leader in biomanufacturing and life sciences MISSISSAUGA, ON, Nov. 19,...
Vee Healthtek Joins TA Associates’ Portfolio with Strategic Growth Investment
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Today, TA Associates ("TA"), a global growth private equity firm, has announced a majority stake...
World-Class Leaders to Headline HIMSS25 Global Conference
LAS VEGAS, Nov. 19, 2024 /PRNewswire/ -- Informa Markets announced an exceptional lineup of keynote speakers for the 2025 HIMSS...
Cmbio: A New Brand Unifying Leaders in Microbiome and Metabolomics Science
COPENHAGEN, Denmark, Nov. 19, 2024 /PRNewswire/ -- Today marks the launch of Cmbio, a new brand that brings together Clinical Microbiomics...
ACTO JOINS VEEVA AI PARTNER PROGRAM TO STRENGTHEN FIELD TEAM MESSAGING DURING FACE-TO-FACE HCP INTERACTIONS
Helping Mutual Customers Elevate the "Human Touch" Element of Their Omnichannel Engagement Strategies MADRID, Nov. 19, 2024 /PRNewswire/ - Veeva Commercial...
Axtria Unveils New Benchmarking Study on Territory Design and Refinement for Life Sciences Companies
Reveals latest trends in territory alignment, balancing workloads, and enhancing sales effectiveness that can help reshape, inform, and modernize commercial...
Jaguar Health Family Company Napo Therapeutics Named “Best Pharmaceuticals Innovator of the Year – Europe”
Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar's novel oral plant-based prescription...
Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate
Webcast and conference call to be held be on Thursday, November 21st at 4:30 pm ET, dial in information belowNEWARK,...
Medera and Singapore’s Cardiovascular Disease National Collaborative Enterprise Launch Asia’s First Cardiac Gene Therapy Trial for Heart Failure
Medera and Cardiovascular Disease National Collaborative Enterprise (CADENCE) announce the initiation of Asia's first cardiac gene therapy clinical trial for...
Phio Pharmaceuticals Announces Completion of Enrollment in Second Cohort in Phase 1b Dose-Escalating Clinical Study
--Six sites across the U.S. are now engaged in Phase1b study Marlborough, Massachusetts--(Newsfile Corp. - November 19, 2024) - Phio...
AMCOR AND BERRY TO COMBINE IN AN ALL-STOCK TRANSACTION, CREATING A GLOBAL LEADER IN CONSUMER AND HEALTHCARE PACKAGING SOLUTIONS
Combination of Complementary Businesses Expands Product Offering and Capabilities to Support Higher Growth for Customers Combined R&D and Innovation Investment...
LINDIS Biotech Signs Licensing Agreement with Pharmanovia for the Commercialization of Catumaxomab
Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024...
GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D
TOKYO, Nov. 18, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is pleased to announce that Open Philanthropy, a grantmaking...
Medical Gas Blenders Market to Grow by USD 582 Million (2024-2028), Driven by Aging Population and Chronic Disease Prevalence, with AI Impacting Market Trends – Technavio
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape - The global medical gas...
Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member
WINNIPEG, MB / ACCESSWIRE / November 18, 2024 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused...
Protagonist Announces Positive Topline Results From Phase 3 ICONIC Studies of Icotrokinra (JNJ-2113) in Plaque Psoriasis, a First-in-Class Investigational Targeted Oral Peptide That Selectively Blocks the IL-23 Receptor
ICONIC-LEAD achieved its co-primary endpoints of PASI-90 and IGA of 0 or 1 at week 16; 74% of patients achieved...
Community Routes: Access to Mental Health Care
US Chamber of Commerce Foundation Citizens Award WinnerNORTHAMPTON, MA / ACCESSWIRE / November 18, 2024 / Teva Pharmaceuticals is proud...
Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week studyEpisodes of pericarditis per year substantially...